Technology Enhanced Behavioral Activation Treatment for Substance Use
2 other identifiers
interventional
206
1 country
2
Brief Summary
The purpose of this study is to:
- 1.test the effect of a smartphone enhanced LETS ACT (LETS ACT-SE) on frequency of substance use
- 2.use functional magnetic resonance imaging (fMRI) to test the relationship between neuromarkers of reward sensitivity on frequency of substance use.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Jan 2016
Longer than P75 for not_applicable
2 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
May 27, 2015
CompletedStudy Start
First participant enrolled
January 1, 2016
CompletedFirst Posted
Study publicly available on registry
March 14, 2016
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2020
CompletedStudy Completion
Last participant's last visit for all outcomes
December 1, 2020
CompletedOctober 16, 2023
January 1, 2021
4.9 years
May 27, 2015
October 13, 2023
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Timeline Followback (TLFB)
The Time Line Follow Back is a self-report measure of drug and alcohol use.
TLFB will be assessed from baseline to a 12-month follow up period.
Secondary Outcomes (8)
Behavioral Activation for Depression Scale (BADS)
BADS will be assessed from baseline to a 12-month follow up period.
Reward Probability Index (RPI)
RPI will be assessed from baseline to a 12-month follow up period.
Beck Depression Inventory-II (BDI-II)
BDI-II will be evaluated from baseline to a 12-month follow up period
Daily Goals Form
Baseline to a 3-months post treatment.
Texas Christian University (TCU) HIV/AIDS Risk Assessment Form
TCU will be assessed from baseline to a 12-month follow up period.
- +3 more secondary outcomes
Study Arms (3)
Treatment as Usual
PLACEBO COMPARATORPatients are offered substance use group therapy including relapse prevention. They are also provided medical consultation on an ongoing basis as needed.
LETS ACT
ACTIVE COMPARATORThe Life Enhancement Treatment for Substance Use (LETS ACT) involves the discussion of the treatment rationale, identification of values and goals in various life areas and activities in line with chosen life areas, and training for patients to identify their cycle of negative mood and behavior using forms to track their daily goals.
LETS ACT-SE
ACTIVE COMPARATORParticipants assigned to the smartphone-enhanced LETS ACT (LETS ACT-SE) condition will be provided the exact same treatment as outlined in LETS ACT, except that LETS ACT-SE participants will record their daily goals using smartphone technology.
Interventions
The Life Enhancement Treatment for Substance Use (LETS ACT)
Participants assigned to the smartphone-enhanced LETS ACT (LETS ACT-SE) condition will be provided the exact same treatment as outlined in LETS ACT, except that LETS ACT-SE participants will record their daily goals using smartphone technology.
Participants will receive the treatment typically provided to patients at the substance use treatment facility.
Eligibility Criteria
You may qualify if:
- Between 18 and 55
- Meet criteria for DSM-V substance use disorder
- Elevated depressive symptoms (BDI ≥ 14)
You may not qualify if:
- Limited mental competency (MMSE \< 23)
- Psychosis
- The use of psychotropic medication for \< 3 months
- The inability to give informed, voluntary, written consent to participate
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (2)
University of North Carolina at Chapel Hill
Chapel Hill, North Carolina, 27599-3270, United States
Southlight Healthcare
Raleigh, North Carolina, 27604, United States
Related Publications (2)
Kane L, Reese ED, Paquette C, Paladino M, Linares Abrego P, Daughters SB. Substance use negatively impacts change in reinforcement during the year following substance use treatment. Psychol Addict Behav. 2025 May;39(3):238-253. doi: 10.1037/adb0001051. Epub 2025 Jan 9.
PMID: 39786834DERIVEDPaquette CE, Rubalcava DT, Chen Y, Anand D, Daughters SB. A Mobile App to Enhance Behavioral Activation Treatment for Substance Use Disorder: App Design, Use, and Integration Into Treatment in the Context of a Randomized Controlled Trial. JMIR Form Res. 2021 Nov 3;5(11):e25749. doi: 10.2196/25749.
PMID: 34730535DERIVED
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Stacey Daughters, Ph.D.
University of North Carolina
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- PARTICIPANT
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
May 27, 2015
First Posted
March 14, 2016
Study Start
January 1, 2016
Primary Completion
December 1, 2020
Study Completion
December 1, 2020
Last Updated
October 16, 2023
Record last verified: 2021-01
Data Sharing
- IPD Sharing
- Will not share